| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/10/2011 | WO2010132389A3 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression |
| 03/10/2011 | WO2010127180A3 Dc-stamp antibodies |
| 03/10/2011 | WO2010115053A9 Methods of using canonical wnts as enhancers for bone formation by human bone-marrow derived mesenchymal stem cells |
| 03/10/2011 | WO2010114319A3 Composition for bone regeneration |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060412 Tissue Engineered Meniscus Repair Composition |
| 03/10/2011 | US20110060290 Stabilized protein compositions |
| 03/10/2011 | US20110060009 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/10/2011 | US20110060004 Imidazo-Pyridine Derivatives as Activin-Like Receptor Kinase (ALK4 or ALK5) Inhibitors |
| 03/10/2011 | US20110059971 Derivatives of 4-aminopiperidine and their use as a medicament |
| 03/10/2011 | US20110059970 4-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands |
| 03/10/2011 | US20110059968 Carboxamide compounds and their use as calpain inhibitors |
| 03/10/2011 | US20110059965 Bicyclic derivatives as modulators of ion channels |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/10/2011 | US20110059952 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 03/10/2011 | US20110059951 HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 03/10/2011 | US20110059945 S1P Receptor Modulating Compounds and Use Thereof |
| 03/10/2011 | US20110059944 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 03/10/2011 | US20110059937 Il-8 receptor antagonists |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059918 Stable Hyaluronan/Steroid Formulation |
| 03/10/2011 | US20110059896 Use of furin convertase inhibitors in the treatment of fibrosis and scarring |
| 03/10/2011 | US20110059891 Alpha-msh therapies for treatment of autoimmune disease |
| 03/10/2011 | US20110059885 Treatment of diseases and conditions mediated by eicosanoids |
| 03/10/2011 | US20110059172 Therapeutic compositions |
| 03/10/2011 | US20110059118 Inhibitors of jak |
| 03/10/2011 | US20110059101 Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling |
| 03/10/2011 | US20110059095 High affinity human antibodies to human protease-activated receptor-2 |
| 03/10/2011 | US20110059083 Agent for treating disease |
| 03/10/2011 | CA2773062A1 A bone regeneration agent comprising gelatin |
| 03/10/2011 | CA2771822A1 Bruton's tyrosine kinase inhibitors |
| 03/10/2011 | CA2694467A1 New method treatment the diseases, which use vitamin e oil in big doses so that of incurable (cancer, arthritis), chronic (diabetes, hypertension), infection (inflammation, virus,bacterium, fungus), regeneration damages (skin, tissue, conjunctive tissue), and in the look the applique, and covering by film |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292665A1 Use of interleukin-4 antagonists and compositions thereof |
| 03/09/2011 | EP2292660A2 Human antibody molecules for IL-13 |
| 03/09/2011 | EP2292614A1 Substituted pyrimidines as aurora kinase inhibitors |
| 03/09/2011 | EP2292611A1 Novel thiophenediamine derivative having urea structure |
| 03/09/2011 | EP2292610A1 Macrolides with VEGF transcription suppression activity |
| 03/09/2011 | EP2292592A1 Sulfonamide compound and application thereof |
| 03/09/2011 | EP2292273A2 Remodeling and glycoconjugation of peptides |
| 03/09/2011 | EP2292271A2 Remodelling and glycoconjugation of an antibody |
| 03/09/2011 | EP2292235A2 Methotrexate solutions |
| 03/09/2011 | EP2292234A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof |
| 03/09/2011 | EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II |
| 03/09/2011 | EP2292223A1 Polyunsaturated fatty acid supplements |
| 03/09/2011 | EP2292091A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/09/2011 | EP2291373A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 03/09/2011 | EP2291371A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 03/09/2011 | EP2291370A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 03/09/2011 | EP2291350A2 Compositions and methods for preparing and using same |
| 03/09/2011 | EP2291189A1 Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same |
| 03/09/2011 | EP1622925B1 Novel method and intermediates for the preparation of 19-nor-steroid compounds |
| 03/09/2011 | EP1513793B1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 03/09/2011 | EP1315513B1 "pseudo"-native chemical ligation |
| 03/09/2011 | CN101983722A Composition for preventing and treating joint soft tissue injury and complications thereof |
| 03/09/2011 | CN101983720A External applied traditional Chinese medicine composition for treating bone hyperplasia and preparation method thereof |
| 03/09/2011 | CN101983713A Traditional Chinese medicine for treating diabetes gout |
| 03/09/2011 | CN101983710A Medicine for external application in orthopedics, production method and application method thereof |
| 03/09/2011 | CN101983706A External used medicine paste for treating various bone hyperplasias and preparation method thereof |
| 03/09/2011 | CN101983666A Traditional Chinese medicine composition for treating rheumatism and preparation method thereof |
| 03/09/2011 | CN101983654A Traditional Chinese medicine for treating femoral head necrosis |
| 03/09/2011 | CN101983653A Drug for treating lumbocrural pain and preparation method thereof |
| 03/09/2011 | CN101983652A Traditional Chinese medicine for treating scapulohumeral periarthritis |
| 03/09/2011 | CN101274049B Medicament for curing multiple traumas |
| 03/09/2011 | CN101060828B Surfactant composition |
| 03/08/2011 | US7902361 Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy |
| 03/08/2011 | US7902179 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease |
| 03/08/2011 | US7902172 Method of promoting bone growth with hyaluronic acid and growth factors |
| 03/08/2011 | US7902149 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 03/08/2011 | US7901917 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 03/08/2011 | US7901894 Kinase inhibitors |
| 03/08/2011 | US7901879 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
| 03/08/2011 | US7901676 Therapeutic composition for the treatment of rheumatoid arthritis |
| 03/08/2011 | US7901672 Methods of making enhanced, autologous fat grafts |
| 03/08/2011 | CA2483764C Arsenic therapy for apls-type autoimmune lymphoproliferative syndrome in mice and humans |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/08/2011 | CA2329054C A novel polypeptide hormone phosphatonin |
| 03/03/2011 | WO2011025541A1 Cannabinoid receptor modulators |
| 03/03/2011 | WO2011025368A1 Method of treating frailty |
| 03/03/2011 | WO2011025086A1 Pharmaceutical composition for preventing or treating rheumatoid arthritis, containing rebamipide |
| 03/03/2011 | WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| 03/03/2011 | WO2011024955A1 Nucleic acid capable of binding to tgf-βii-type receptor, and use thereof |
| 03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
| 03/03/2011 | WO2011022757A1 Purine-targeted diagnosis and therapy of wounds |
| 03/03/2011 | WO2011022753A1 Composition and method for the treatment or prevention of spinal disorders iii |
| 03/03/2011 | WO2010124283A3 Methods and compositions relating to hematologic malignancies |
| 03/03/2011 | WO2010123919A3 Piperidine inhibitors of janus kinase 3 |
| 03/03/2011 | WO2010111240A3 Methods for treating inflammatory arthritis |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110054032 Dioxoanthracene sulphonate derivatives |
| 03/03/2011 | US20110054020 Napthylene inhibitors of cyclooxygenase |
| 03/03/2011 | US20110053983 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 03/03/2011 | US20110053974 Carboxylic acid compound |
| 03/03/2011 | US20110053973 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053972 Inhibitors of akt activity |
| 03/03/2011 | US20110053960 Method for treating pain syndrome and other disorders |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 |